Previous Close | 9.22 |
Open | 9.41 |
Bid | 9.61 x 200 |
Ask | 9.65 x 100 |
Day's Range | 9.19 - 9.74 |
52 Week Range | 6.57 - 22.93 |
Volume | |
Avg. Volume | 1,190,693 |
Market Cap | 917.966M |
Beta (5Y Monthly) | 0.95 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Rohan Palekar, CEO of 89bio Inc (NASDAQ:ETNB), executed a sale of 52,718 shares in the company on April 1, 2024, according to a recent SEC Filing.
In this article, we’re going to take a look at 13 best biotech stocks to buy under $20. To see more stocks that made the list, you can skip ahead and jump straight to the top 5 best biotech stocks to buy under $20. When it comes to investing, few industries are as exciting to […]
Akero (AKRO) reports positive results from its mid-stage study of efruxifermin in pre-cirrhotic metabolic dysfunction-associated steatohepatitis patients at week 96. The stock gains 12%.